Jon Congleton

Director & Chief Executive Officer

Director & Chief Executive Officer at Mineralys Therapeutics, Inc., filing insider transactions between 2026-07-13 and 2026-09-30.

Total Purchases

—

0 transactions

Total Sales

$2.2M

2 transactions

Companies Traded

2 total filings

Active Since

2026-07-13

Last: 2026-09-30

Companies

Mineralys Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-09-30	MLYS	Sale	75.0K	$25.46	$1.9M	528.6K	SEC ↗
2026-07-13	MLYS	Sale	10.7K	$27.24	$291K	603.6K	SEC ↗